It is good that you are now unbaffled why posters talk about the lack of funds NXE has
"....but they will still have some money..." is pretty glib.
The Companies own anns paint a very clear picture of the funds situation and it is obvious they have very little funds for progressing anything and (depending on the Arena claim) whether they even have enough for working capital is questionable (all detailed previously).
Of course a Company like this will often be in a position of needing capital, however the question of how they raise should really be discussed in context of what it means to holders.
The point is, recent deals have significantly changed the asset structure to the detriment of small holders and after the deal the NXE still has no funds currently available to put toward progressing Caula!! (It is plainly obvious they have little option however as I have said before the deal involving selling half the asset holding Company is bad business and shareholders should actively oppose this)
After settlement the Ching group will own 15.4% of NXE and Regius will own 12% of NXE while NXE will now own only 40% of tenement JL6678L and even less of other tenements
You never know, when the Fura shares eventually get issued and out of escrow they might be able to sell them to fund a couple of quarters tea and biscuits.........................
- Forums
- ASX - By Stock
- G79
- Ann: Strategic Investor, Equity Placement & JV Partner for Caula
Ann: Strategic Investor, Equity Placement & JV Partner for Caula, page-72
Featured News
Add G79 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online